本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TriSalus Life Sciences Inc.

4.63
-0.0350-0.75%
成交量:828
成交額:3,835.89
市值:2.84億
市盈率:-3.48
高:4.63
開:4.63
低:4.63
收:4.67
52周最高:7.95
52周最低:2.20
股本:6,130.64萬
流通股本:4,363.12萬
量比:0.23
換手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-1.3300
每股收益(LYR):-1.8389
淨資產收益率:-496.21%
總資產收益率:-36.75%
市淨率:43.34
市盈率(LYR):-2.52

資料載入中...

2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/19

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/18

SEC問詢函

Form CORRESP - Correspondence
2023/10/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/02

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/31

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/08/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/23

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/21

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/21

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/16

重要事件披露

Form 8-K - Current report